Mode
Text Size
Log in / Sign up

Cross-sectional survey examines e-cigarette use among US middle and high school students

Cross-sectional survey examines e-cigarette use among US middle and high school students
Photo by Navy Medicine / Unsplash
Key Takeaway
Note: Surveillance report on adolescent e-cigarette use lacks specific results and methodological details.

A cross-sectional surveillance report examined e-cigarette use among middle and high school students in the United States. The study type was described as a survey, but key methodological details including sample size, specific survey questions, and data collection timeframe were not reported. No intervention, exposure, or comparator groups were specified in the available information.

The report did not provide any quantitative results regarding e-cigarette use prevalence, patterns, or associated factors. No numerical data, effect sizes, confidence intervals, or p-values were reported for any outcomes. The direction of findings and specific measures of e-cigarette use were not detailed in the available summary.

Safety and tolerability information was not reported, including any adverse events or discontinuations related to e-cigarette use. The report did not mention funding sources or potential conflicts of interest that might inform interpretation of the findings.

Key limitations include the absence of reported results, sample size, and methodological details that would allow assessment of survey quality. Without comparative data or longitudinal design, this report cannot inform trends in e-cigarette use over time. The practice relevance is limited to suggesting ongoing surveillance of e-cigarette use in adolescent populations, though clinicians should seek more detailed data for informed practice.

Study Details

EvidenceLevel 5
PublishedOct 2022
View Original Abstract ↓
This report describes e-cigarette use among middle and high school students in the United States.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.